Schadt Eric insider trades
Schadt Eric has filed 11 Form 4s with the SEC that we hold, all for GeneDx Holdings Corp. (SMFR), as President & Chief R&D Officer, Director. Across all of them we count 1 purchase worth $192.0K and 3 sales worth $412.2K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 33,332 shares of GeneDx Holdings Corp. worth $251.3K, dated 2021-10-25. The first filing on our record is dated 2021-07-26 and the latest 2022-05-24.
GeneDx Holdings Corp. (SMFR)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-10-25 | S, sale reported on Form 4 | 33,332 | $251.3K | 2021-11-02 |
| 2022-01-28 | S, sale reported on Form 4 | 29,100 | $82.6K | 2022-02-02 |
| 2022-04-28 | S, sale reported on Form 4 | 35,899 | $78.3K | 2022-05-02 |
| 2022-05-20 | P, purchase reported on Form 4 | 100,000 | $192.0K | 2022-05-24 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1873468) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms